2025 Market Access Guide for Biotech: What is essential and what is a waste of resources
In the competitive and resource-constrained world of biotechnology, achieving market access and reimbursement is critical. Many biotechs target partnering or
Joint Clinical Assessment (JCA) in the EU: The European Commission adopted the Implementing Act on Joint Clinical Assessment
The implementation of the Joint Clinical Assessment (JCA) in the European Union represents a notable step forward in assessing innovative
Germany’s New 2024 Medical Research Act Law
On July 4, 2024, the Bundestag (German Parliament) passed significant amendments to the country’s drug pricing and reimbursement laws as
2024 Neue Preisstrategien für die EU-5
Was Sie über vertrauliche Rabatte und Nettopreise in der EU-5 wissen müssen In der EU-5 (Frankreich, Deutschland, Italien, Spanien und
Key insights from the new draft regulation on the communication with the European Medicines Agency
The new Joint Clinical Assessment (JCA) and Joint Scientific Consultation (JSC) initiatives, which are part of the European-wide Health Technology
The US Inflation Reduction Act – key changes to Pricing & Reimbursement of medicines in the USA you need to know about
The Inflation Reduction Act (IRA), signed into law in August 2022, is a piece of legislation aimed at addressing several
